Walleye Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.48M | Buy |
190,373
+66,391
| +54% | +$1.91M | 0.02% | 381 |
|
|
2025
Q1 | $4.16M | Sell |
123,982
-17,856
| -13% | -$599K | 0.02% | 395 |
|
|
2024
Q4 | $7.25M | Sell |
141,838
-79,108
| -36% | -$4.04M | 0.02% | 340 |
|
|
2024
Q3 | $11.3M | Sell |
220,946
-94,274
| -30% | -$4.82M | 0.02% | 236 |
|
|
2024
Q2 | $14.1M | Buy |
315,220
+73,858
| +31% | +$3.31M | 0.03% | 175 |
|
|
2024
Q1 | $11.3M | Sell |
241,362
-27,726
| -10% | -$1.3M | 0.02% | 227 |
|
|
2023
Q4 | $9.57M | Sell |
269,088
-165,822
| -38% | -$5.9M | 0.02% | 207 |
|
|
2023
Q3 | $12.9M | Buy |
434,910
+121,312
| +39% | +$3.61M | 0.03% | 147 |
|
|
2023
Q2 | $5.65M | Sell |
313,598
-120,097
| -28% | -$2.16M | 0.02% | 263 |
|
|
2023
Q1 | $6.97M | Buy |
433,695
+28,136
| +7% | +$452K | 0.1% | 207 |
|
|
2022
Q4 | $7.42M | Buy |
405,559
+155,545
| +62% | +$2.85M | 0.14% | 177 |
|
|
2022
Q3 | $4.91M | Buy |
250,014
+95,922
| +62% | +$1.88M | 0.09% | 222 |
|
|
2022
Q2 | $2.87M | Sell |
154,092
-29,451
| -16% | -$549K | 0.08% | 267 |
|
|
2022
Q1 | $4.03M | Buy |
183,543
+95,935
| +110% | +$2.11M | 0.11% | 188 |
|
|
2021
Q4 | $2.49M | Buy |
+87,608
| New | +$2.49M | 0.08% | 272 |
|
|
2021
Q1 | – | Sell |
-12,100
| Closed | -$171 | – | 1191 |
|
|
2020
Q4 | $171 | Buy |
+12,100
| New | +$171 | 0.01% | 735 |
|